FDA
-
-
-
-
-
-
-
OSE Immunotherapeutics Announces Corporate Update and H1 2022 Results
-
-
-
-
-
-
-
OSE Immunotherapeutics Announces H1 2021 Results and Provides a Corporate Update
-
-
-
-
-
-
-
OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update
322,245 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

